🇺🇸 12 months of P2Y12 receptor antagonist in United States

12 months of P2Y12 receptor antagonist (12 months of P2Y12 receptor antagonist) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

12 months of P2Y12 receptor antagonist in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 12 months of P2Y12 receptor antagonist approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for 12 months of P2Y12 receptor antagonist in United States?

Beijing Anzhen Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.